INOVIQ (ASX:IIQ) has reported promising preclinical results for its CAR-NK-exosome therapy, confirming rapid and potent tumour-killing activity in triple-negative breast cancer (TNBC) cells. …
INOVIQ’s CAR-NK exosomes show potent tumour-killing effect in breast cancer study
September 24, 2025 Australian Biotech
Latest Video
New Stories
-
OncoSil completes first production run at new Sydney manufacturing facility
December 17, 2025 - - Australian Biotech -
Island Pharmaceuticals secures key partnership with Texas Biomed
December 17, 2025 - - Australian Biotech -
Novartis names new Country President following leadership transition
December 16, 2025 - - Latest News -
Mayne Pharma opens expanded manufacturing facility after termination of takeover
December 16, 2025 - - Latest News -
Budget update includes impact of listings, but generally not much else
December 16, 2025 - - Latest News -
The UK reconfirms the direct impact of the transatlantic shift in medicine pricing
December 16, 2025 - - Latest News -
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - - Latest News